Invites Genomics

Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. The company aggregates world-class genetic tests into a single service with higher quality, faster turnaround time, and lower prices than traditional providers. Invitae offers a wide range of genetic testing services across various clinical areas, including oncology, cardiology, neurology, and reproductive health. Following a period of rapid expansion and subsequent financial restructuring, the company's assets were largely acquired by Labcorp in 2024, ensuring the continued availability of its critical diagnostic services.